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Introduction
Squamous cell carcinoma of the larynx is the major
public health problem. Treatment of this cancer by
chemotherapy applied until late 1970s had a relative-
ly poor response in patients. The use of cisplatin
(CDDP) or cisplatin and 5-fluorouracil (5-FU) com-
bination treatment regimens showed benefit results in
chemosensitive laryngeal tumors [1,2]. CDDP is 
a chemotherapeutical agent exhibiting activity
against many types of human malignancies including
testicular and ovarian cancers or bladder, lung and
head and neck tumors [3-5]. CDDP interacts with cel-
lular proteins, lipids and forms covalent DNA
adducts causing cell cycle arrest in phase G2+M
[3,4]. Cellular response to CDDP action occurs both
in cell-interdependent and cell-autonomous path-
ways. In cell-interdependent communication mecha-
nisms, cytotoxic signal transduction, control of cell
proliferation, differentiation and apoptosis is mediat-
ed via gap-junctional intercellular communication
(GIJC). Gap junctions (intercellular channels) are
formed by protein subunits known as connexins,
which oligomerize to the hexameric structure, the
connexons [6,7]. Connexons from adjacent cells
interact, forming intercellular channels which cluster
in specialized membrane regions called gap junc-
tions. Through these channels, molecules exchange
among neighboring cells without secreting them into
the extracellular space [6]. 
In the present study we analysed cisplatin action on
the motility and gap-junction intercellular communica-
tion in two new cell cultures (RK33 and RK45)
derived from human laryngeal carcinoma.
Materials and methods
Cell cultures. RK33 and RK45 cell lines were characterized in our
previous study [8]. RK33 cell line was established from a tumor
fragment at T3 stage taken from 50-years old woman after laryn-
gectomy. RK45 cell line was established from a tumor fragment at
T3 stage obtained from a 61-years old man. Cultures were kept at
37°C in a humidified atmosphere with 5% CO2. Cells were sub-
cultured to 25 cm2 tissue culture flasks (Nunc.) using 0.25%
trypsin-EDTA (Sigma) solution.
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MTT assay. Sensitivity of cells to CDDP (0.5 μg/ml and 
1.5 μg/ml) was determined by a standard spectrophotometric 
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. Cells grown in 96-well multiplates in 100 μl of culture
medium supplemented with 2% FBS were incubated for 3h with
MTT solution (5 mg/ml, 25 μl/well) (Sigma). The yellow tetrazoli-
um salt was metabolized by viable cells to purple crystals of for-
mazan. The crystals were solubilized overnight in a solution consist-
ing of 10% sodium dodecyl sulfate (SDS) (Sigma) in 0.01 M HCl.
The product was quantified spectrophotometrically by absorbance
measurement at 570 nm wavelength using an E-max Microplate
Reader (Molecular Devices Corporation, Menlo Park, CA, USA).
Neutral red (NR) uptake assay. Cells were grown in 96-well mul-
tiplates in 100 μl of culture medium (RPMI 1640) supplemented
with 2% FBS and CDDP (0.5 μg/ml and 1.5 μg/ml). Subsequently,
the medium was discarded and 0.4% NR (Sigma) solution in 
2% FBS medium was added to each well. The plate was incubated
for 3h at 37°C in a humidified 5% CO2/95% air incubator. After
incubation, the dye-containing medium was removed, cells fixed
with 1% CaCl2 in 4% paraformaldehyde and thereafter the incor-
porated dye was solubilized using 1% acetic acetate in 50%
ethanol solution (100 μl). The plates were gently shacked for 
20 min at room temperature and the extracted dye absorbance was
spectrophotometrically measured at 540 nm.
Cell migration assessment. Tumor cell migration was assessed in
the wound assay model as previously described [9]. Tumor cells
were plated at 1×106 cells on 4 cm culture dishes (Nunc). Next day,
the cell monolayer was scratched by the pipette tip (P300), the
medium and dislodged, cells were aspirated and the plates rinsed
twice with PBS. Next, the fresh culture medium was applied and
the number of cells migrated into the wound area after 24 hours
was estimated in the control and the cultures treated with cisplatin
(1.5 μg/ml). The plates were stained with the May-Grünwald-
Giemsa method. The observation was performed in Olympus
BX51 System Microscope (Olympus Optical CO., LTD, Tokyo,
Japan) and the micrographs were prepared in analySIS® software
(Soft Imaging System GmbH, Münster, Germany). Cells migrated
to the wound area were counted on micrographs and results
expressed as a mean cell number migrated to the selected 
50 wound areas taken from 4 micrographs. 
Lucifer Yellow dye transfer through gap junction channels
assay. Tumor cells were plated on Petri dishes at a density of 
1×105 cells/ml for 2 days. When cells reached confluence, the medi-
um was removed and cells were exposed for 24h to CDDP
(0.5 μg/ml) in RPMI 1640 medium containing 2% FCS. Thereafter,
the medium was discarded and 0.5 mg/ml Lucifer Yellow CH lithi-
um salt solution was added to the cell monolayers. Using 
a sterile scalpel blade a wound cells (monolayer scarification) was
performed in a straight line. The plate was left for 3 min in dark for
complete dye-loading transfer to adjacent cells, rinsed with PBS
containing Ca2+ and Mg2+ and fixed with 4% (v/v) formaldehyde.
Plates were analyzed in a fluorescent Olympus BX51 microscope
with UV light source and micrographs were prepared using Ana-
lySIS software.
Statistical analysis. Results are presented as means ±SD. Data
were analyzed with t-student's test. Differences of p<0.05 were
considered significant.
Results
In our previous study [8] we reported a successful
establishment of two cell lines (RK33 and RK45)
derived from two laryngeal carcinomas. Both cell lines
exhibited similar sensitivity to etoposide, thiotepa and
methotrexate. The present study was performed to ana-
lyze the chemosensitivity of these cell lines to CDDP
and the effect of the drug on cells migration capacity
and cellular communication via gap junctions. Viabili-
ty of tumor cells were above 94% after 24h incubation
with 1.5 μg/ml CDDP and 98% with 0.5 μg/ml CDDP
as measured by MTT and NR uptake assay. In LY
method we used lower CDDP concentration 
(0.5 μg/ml) to analyze only changes in dye migration
through connexons after CDDP application without
any disturbances associated with CDDP influence on
cell membrane lipids and proteins.
The effect of CDDP on RK33 and RK45 tumor
cells motility was assessed by means of the wound
assay (Fig.1). The assay revealed that similar amounts
of tumor RK33 cells migrated to the wound area in
control and CDDP exposed cultures (Table 2). Howev-
er, CDDP treatment caused less number of RK45 cells
migrated to the wound area in comparison to control
but the differences were not significant (Table 1). 
Gap junctions cellular communication was tested
using Lucifer Yellow (LY) dye (Mm 457 Da) which
easily passes through connexon channels. Cells loaded
with the dye diffuse it to another via gap junctions. LY
is brightly fluorescent and its migration can be visual-
ized under UV light sourced microscope. The results
are shown in Fig. 2. Incubation of tumor cells with
CDDP resulted in farther LY migration through neigh-
boring cells beyond monolayer wound than in control
cultures. The LY migration distance in CDDP treated
cultures was significant in both cell lines in compari-
son with appropriate controls; RK33 (p<0.01), RK45
(p<0.05) as analyzed by t-student's test.
Discussion
This study presents the relationship between the motil-
ity of laryngeal carcinoma cells and intercellular com-
munication via gap junctions after CDDP treatment. 
CDDP is a well established chemotherapeutic agent
used in the treatment of many cancers, also head and
neck tumors. However, mechanisms of platinum
resistance may reduce a therapeutic effects of this drug
[10]. The main criterion of 0.5 μg/ml and 1.5 μg/ml of
CDDP doses selection was based on their slight influ-
ence on laryngeal tumor cell viability but measurably
effects on tumor cells functions. Moreover, in our pre-
vious study [11] we showed that 0.5 μg/ml of CDDP
significantly increase P53 with simultaneous decreas-
es in BCL-2 proteins expression. We also found that
CDDP in this dose increase syndecan-1 expression in
laryngeal cancers what may influence on tumor cells
adhesive properties and possibility of metastasis
occurrence [12].
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Fig. 1. The effect of cisplatin on the migration capacity of tumor cells in wound assay. (A) Wounded monolayer of RK33 and RK45 cell
lines. (B)Tumor cell migration after 24h in control cultures. (C) Tumor cell migration after 24h incubation with 1.5  μg/ml cisplatin (bar
500 μm, original magnification ×40).
Our observations revealed that RK33 cells were more
sensitive to CDDP action than RK45. However, this did
not affect the migration of RK33 cells but limited gap
junction communication as compared with RK45 cells.
On the other hand, CDDP reduced amount of migrating
RK45 cells, that was associated with better intercellular
communication in comparison with RK33 cell line.
Taken together, the results of our study demonstrate
that there may be an important role of gap junctions in
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Fig. 2. The effect of cisplatin (0.5 μg/ml) on fluorescent dye Lucifer Yellow (LY) diffusion via connexon channels in RK33 and RK45
larynx tumor cell lines. LY is brightly fluorescent dye (Mm 457 Da), easily passing through connexon channels to other adjacent cells.
The migration distance is visualized under UV light sourced microscope. The LY migration distance in CDDP treated cultures was sig-
nificant in both cell lines in comparison with the appropriate controls; RK33 (p<0.01), RK45 (p<0.05) as analyzed by t-student's test (bar
200 μm, original magnification ×100).
Table 1. Tumor cells migration in wound assay. Results are
expressed as mean number of cells migrated per field of the wound
area ± SD of 50 measurements.
mediating CDDP killing and inhibiting migration of
tumor cells. Our results are in consistence with Jensen
and Glazer [13] who showed that cell-interdependent
pathway plays a substantial role in the overall cell
killing only if there is a sufficient cell-to-cell contact
and GJIC are functional. In low drug concentrations,
inhibiting of cell migration may be observed. On the
other hand, cytotoxicity of CDDP in RK33 cell line
could occur via cell-autonomous basis, where unre-
paired platinum-DNA adducts blocked transcription
and replication. It also could be a result of less strict
monolayer formation by RK33 cells than RK45. More-
over, Lee at al. [14] indicated that connexins may
function as tumor suppressor genes. Therefore, the bet-
ter intracellular communication and in consequence
toxic metabolites or low molecular drugs exchange via
gap junctions, the more markedly visible inhibition of
tumor cells growth [14]. It was also shown that down-
regulation of connexin43 increased resistance to
CDDP of human wild-type cancer cell lines. Other
experiments revealed that cytotoxic or inhibitory sig-
nals can be transmitted to neighboring cells but not to
cells deficient in GJIC [13]. 
Summing up, it seems that our results are in con-
sistence with results of other authors who show that
the response of laryngeal tumor cells to CDDP occurs
through cell-interdependent and cell-autonomous
pathways. However, gap junction cellular communica-
tion is the most important in mediating cell migration
inhibitory signals. Our results showed that laryngeal
carcinoma cell lines derived from tumors of two
patients exhibit different sensitivity to CDDP action.
We found the differences in cell motility and diffusion
of the fluorescent dye Lucifer Yellow via connexon
channels connecting the adjacent cells. Therefore, the
examination of gap junction expression among tumor
cells may be helpful in limiting the invasiveness of
tumor cells.
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